Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
145.54
Dollar change
+0.09
Percentage change
0.06
%
IndexDJIA, S&P 500 P/E20.96 EPS (ttm)6.94 Insider Own0.16% Shs Outstand2.41B Perf Week-1.05%
Market Cap350.27B Forward P/E13.32 EPS next Y10.93 Insider Trans-1.74% Shs Float2.40B Perf Month-4.67%
Income17.49B PEG4.03 EPS next Q2.71 Inst Own71.85% Short Float0.83% Perf Quarter-7.99%
Sales89.66B P/S3.91 EPS this Y7.18% Inst Trans-0.39% Short Ratio2.62 Perf Half Y-6.58%
Book/sh29.09 P/B5.00 EPS next Y2.78% ROA9.15% Short Interest19.93M Perf Year-9.92%
Cash/sh10.89 P/C13.36 EPS next 5Y5.20% ROE23.91% 52W Range143.13 - 175.97 Perf YTD-7.15%
Dividend Est.4.81 (3.31%) P/FCF18.73 EPS past 5Y-0.27% ROI18.39% 52W High-17.29% Beta0.52
Dividend TTM4.81 (3.30%) Quick Ratio0.94 Sales past 5Y1.31% Gross Margin68.49% 52W Low1.68% ATR (14)2.17
Dividend Ex-DateMay 20, 2024 Current Ratio1.17 EPS Y/Y TTM44.66% Oper. Margin25.66% RSI (14)41.15 Volatility1.34% 1.49%
Employees131900 Debt/Eq0.48 Sales Y/Y TTM-6.90% Profit Margin19.51% Recom2.21 Target Price171.77
Option/ShortYes / Yes LT Debt/Eq0.36 EPS Q/Q5231.80% Payout84.93% Rel Volume0.53 Prev Close145.45
Sales Surprise-0.08% EPS Surprise2.04% Sales Q/Q-13.55% EarningsApr 16 BMO Avg Volume7.61M Price145.54
SMA20-1.73% SMA50-2.07% SMA200-6.03% Trades Volume4,075,342 Change0.06%
Date Action Analyst Rating Change Price Target Change
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Mar-29-23Initiated UBS Neutral $164
Mar-01-23Initiated Guggenheim Neutral $161
Nov-18-22Initiated Credit Suisse Neutral $170
Jun-15-24 06:42AM
06:00AM
03:30AM
Jun-14-24 11:45AM
08:00AM
05:00AM Loading…
05:00AM
Jun-13-24 09:00AM
Jun-12-24 02:26PM
11:17AM
07:30AM
06:10AM
Jun-11-24 05:45PM
03:16PM
02:49PM
02:09PM
01:12PM Loading…
01:12PM
01:00PM
04:41AM
Jun-10-24 08:00AM
07:10AM
06:00AM
06:00AM
Jun-07-24 12:39PM
07:10AM
04:21AM
Jun-06-24 02:44PM
02:25PM
01:53PM
10:05AM
06:55AM
05:45PM Loading…
Jun-05-24 05:45PM
09:47AM
04:25AM
Jun-04-24 04:30PM
10:00AM
06:00AM
Jun-03-24 03:41PM
02:01PM
06:46AM
06:00AM
Jun-01-24 02:45PM
05:50AM
May-31-24 11:39PM
11:38PM
12:20PM
12:18PM
11:00AM
10:57AM
08:45AM
07:08AM
07:00AM
May-30-24 05:45PM
12:27PM
09:31AM
07:30AM
06:06AM
05:47AM
May-29-24 05:48PM
02:55PM
09:00AM
08:21AM
07:20AM
May-28-24 02:15PM
07:35AM
07:30AM
06:54AM
06:00AM
May-27-24 08:00AM
06:00AM
05:21AM
May-26-24 07:05AM
May-25-24 07:30AM
May-24-24 05:45PM
01:00PM
12:07PM
May-23-24 03:41PM
03:23PM
01:40PM
May-22-24 05:22PM
05:17PM
03:11PM
11:11AM
09:48AM
06:31AM
May-21-24 01:41PM
10:57AM
07:11AM
May-20-24 01:22PM
10:52AM
07:22AM
07:01AM
06:12AM
May-17-24 05:20PM
11:56AM
07:11AM
06:30AM
06:24AM
May-16-24 04:37PM
02:35PM
01:41PM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '24Option Exercise0.0022,255022,561May 03 04:31 PM
Broadhurst VanessaEVP, Global Corp AffairsMar 13 '24Sale162.168,8911,441,76515,043Mar 13 04:36 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM
JOHNSON & JOHNSON10% OwnerFeb 16 '24Sale25.813,72596,1424,099,575Mar 06 03:42 PM
Decker Robert JVP Corporate ControllerFeb 13 '24Option Exercise0.00313019,059Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '24Option Exercise0.00408024,143Feb 15 04:53 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '24Option Exercise0.0065108,576Feb 15 04:53 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '24Option Exercise0.003,4700364,809Feb 15 04:53 PM
Hait WilliamSee RemarksFeb 13 '24Option Exercise0.00834039,074Feb 15 04:53 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13 '24Option Exercise0.009250112,550Feb 15 04:53 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '24Option Exercise0.00499013,290Feb 15 04:53 PM
Swanson James D.EVP, CIOFeb 13 '24Option Exercise0.00447014,765Feb 15 04:53 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '24Option Exercise0.001,3020155,517Feb 15 04:53 PM
Wolk Joseph JExec VP, CFOFeb 13 '24Option Exercise0.001,780069,663Feb 15 04:53 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '24Option Exercise0.00651082,599Feb 15 04:53 PM
Decker Robert JVP Corporate ControllerFeb 12 '24Option Exercise0.001,912019,269Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 12 '24Option Exercise0.0036,6180377,239Feb 14 06:36 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 12 '24Option Exercise0.0026,2020167,618Feb 14 06:36 PM
Forminard ElizabethExecutive VP, General CounselFeb 12 '24Option Exercise0.002,85908,959Feb 14 06:36 PM
Wolk Joseph JExec VP, CFOFeb 12 '24Option Exercise0.0025,835078,699Feb 14 06:36 PM
Hait WilliamSee RemarksFeb 12 '24Option Exercise0.008,932042,316Feb 14 06:36 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 12 '24Option Exercise0.004,701025,081Feb 14 06:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 12 '24Option Exercise0.0013,813089,014Feb 14 06:36 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 12 '24Option Exercise0.005,736015,678Feb 14 06:36 PM
Swanson James D.EVP, CIOFeb 12 '24Option Exercise0.005,456016,013Feb 14 06:36 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12 '24Option Exercise0.0014,9600118,644Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 09 '24Option Exercise90.44130,96911,844,836439,283Feb 13 05:18 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Option Exercise90.4459,3975,371,865200,813Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Sale156.2759,3979,281,969141,416Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08 '24Option Exercise0.003,7390143,329Feb 12 07:25 PM
Decker Robert JVP Corporate ControllerFeb 08 '24Option Exercise0.00655017,572Feb 12 07:24 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 08 '24Option Exercise0.001,880021,083Feb 12 07:24 PM
Hait WilliamSee RemarksFeb 08 '24Option Exercise0.003,059034,497Feb 12 07:24 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08 '24Option Exercise0.002,1350104,465Feb 12 07:24 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 08 '24Option Exercise0.001,964010,943Feb 12 07:24 PM
Swanson James D.See RemarksFeb 08 '24Option Exercise0.001,868011,111Feb 12 07:24 PM
Forminard ElizabethExecutive VP, General CounselFeb 08 '24Option Exercise0.0097906,463Feb 12 07:24 PM
Wolk Joseph JExec VP, CFOFeb 08 '24Option Exercise0.003,686053,911Feb 12 07:25 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 08 '24Option Exercise0.001,971067,905Feb 12 07:25 PM
Duato JoaquinCEO and Chairman of the BoardFeb 08 '24Option Exercise0.005,2250310,583Feb 12 07:25 PM
Hait WilliamSee RemarksJul 26 '23Option Exercise90.4414,6981,329,287102,445Jul 27 05:52 PM
Hait WilliamSee RemarksJul 26 '23Sale172.0014,6982,528,05687,747Jul 27 05:52 PM
Fasolo PeterExec VP, Chief HR OfficerJul 25 '23Sale170.3220,0003,406,498102,696Jul 27 05:52 PM